UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
ETTX holding history
Entasis Therapeutics Holdings Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ETTX overviewAll 13F holders of ETTXFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −12,179−100.0% | Sold out | Holders |
| Q2 2022 | 12,179 | $27.0K | <0.1% | +4,604+60.8% | Added | Holders |
| Q1 2022 | 7,575 | $14.0K | <0.1% | +7,575 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −5,310−100.0% | Sold out | Holders |
| Q3 2021 | 5,310 | $18.0K | <0.1% | +5,207+5,055.3% | Added | Holders |
| Q2 2021 | 103 | $0 | 0.0% | +103 | New | Holders |